Catechol-based phosphoramidites:A New Class of Chiral Ligands for Rhodium-Catalyzed Asymmetric Hydrogenations by Hoen, Rob et al.
  
 University of Groningen
Catechol-based phosphoramidites
Hoen, Rob; Berg, Michel van den; Bernsmann, Heiko; Minnaard, Adriaan J.; Vries, Johannes





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2004
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Hoen, R., Berg, M. V. D., Bernsmann, H., Minnaard, A. J., Vries, J. G. D., & Feringa, B. (2004). Catechol-
based phosphoramidites: A New Class of Chiral Ligands for Rhodium-Catalyzed Asymmetric
Hydrogenations. Organic letters, 6(9), 1433-1436. https://doi.org/10.1002/chin.200436023
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the





Catechol-based Phosphoramidites: A New Class of Chiral Ligands 
for Rhodium- Catalyzed Asymmetric Hydrogenations. 
 
Rob Hoen, Michel van den Berg, Heiko Bernsmann, Adriaan J. Minnaard, Johannes G. de 




All reactions were performed in a dry argon atmosphere using standard 
Schlenk techniques. Et2O (Na), CH2Cl2 (CaH) and EtOAc (boiling chips) were 
destilled before use. The chiral amines for L1 – L9 were commercially 
available or made by literature procedures1. 1H-NMR, 13C-NMR and 31P-NMR 
spectra were recorded on a Varian Gemini-200 (50.32 Hz) or an Varian 300 




General procedure ligand synthesis: 
 
To a solution of 1.5 g. ( 8.60 mmol) of o-phenylenephosphorochloridite and 
0.87 g. ( 8.60 mmol ) of Et3N in 5 ml of Et2O was added a solution of 8.60 
mmol of the appropriate amine in 5 ml Et2O at 0°C. This suspension was 
warmed to RT and stirred for 1.5 hrs. The reaction mixture was filtered over 
celite. The filtrate was concentrated. The ligand was purified by filtration over 




1H NMR (200 MHz) δ = 7.26-7.14 (m, 12H), 7.01-6.98 (m, 2H), 
4.45 (m, 2H), 1.79 (dd, J = 1.8, 7.1,  6H); 13C NMR (50.32 MHz) 
δ = 146.8, 142.0, 129.1, 127.9, 127.7, 127.6, 126.9, 121.7, 53.3, 
53.0, 22.4, 22.2; 31P NMR (81 MHz) δ = 151.9; HRMS 
calculated for C22H22NO2P 363.138 found 363.138; [α]D = -264° 
(c= 0.79, CHCl3). 
 
1H NMR (200 MHz) δ =7.35-7.13 (m, 10H), 6.96-6.78 (m, 4H), 
4.34-4.29 (m, 1H), 3.69 (ddd, J = 6.8, 15.7, 33.8, 2H), 1.43 (dd, 
J = 1.8, 7.1, 3H); 13C NMR (50.32 MHz) δ = 146.7, 146.6, 146.5, 
146.3, 141.9, 138.4, 128.5, 128.3, 128.1, 127.3, 127.2, 121.7, 
111.4, 56.2, 55.9, 47.2, 47.1, 22.3, 22.1; 31P NMR (81 MHz) δ 
=146.1; HRMS calculated for C22H22NO2P 349.123 found 
349.122; [α]D = -21° (c= 1.17, CHCl3). 
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1H NMR (200 MHz) δ =7.42-7.22 (m, 5H), 7.04-6.95 (m, 2H), 
6.90-6.81 (m, 2H), 4.43-4.37 (m, 1H), 3.18-3.05 (m, 1H), 1.54 
(dd, J = 0.5, 7.1, 3H), 1.35 (d, J = 6.8, 3H), 0.96 (d, J = 6.8, 3H); 
13C NMR (50.32 MHz) δ = 146.7, 128.2, 127.6, 127.0, 121.6, 
111.4, 52.5, 52.4, 46.5, 46.1, 26.3, 26.1, 25.1, 24.9, 20.7, 20.6; 
31P NMR (81 MHz) δ = 152.5; HRMS calculated for C17H20NO2P 
301.123 found 301.123; [α]D = +214° (c= 1.02, CHCl3). 
 
1H NMR (200 MHz) δ = 7.45-7.28 (m, 5H), 7.06-6.89 (m, 4H), 
4.73-4.65 (m, 1H), 2.79-2.64 (m, 2H), 1.69 (dd, J = 1.6, 7.2, 3H), 
0.89 (t, J = 7.1, 3H); 13C NMR (50.32 MHz) δ =146.7, 146.6, 
146.4, 142.3, 142.3, 128.4, 127.1, 121.6, 111.2, 55.7, 55.1, 
37.2, 37.1, 21.5, 21.2, 17.0, 16.9; 31P NMR (81 MHz) δ =149.5; 
HRMS calculated for C16H18NO2P 287.108 found 287.108; [α]D = 
-65° (c= 1.36, CHCl3). 
 
1H NMR (200 MHz) δ = 7.42-7.26 (m, 5H), 7.05-6.97 (m, 2H), 
6.94-6.87 (m, 2H), 4.79-4.71 (m, 1H), 2.20 (d, J = 6.1, 3H), 1.59 
(dd, J = 0.6, 7.0, 3H); 13C NMR (50.32 MHz) δ = 146.7, 141.0, 
128.4, 127.1, 121.6, 111.1, 55.0, 54.4, 26.2, 26.1, 18.8, 18.6; 
31P NMR (81 MHz) δ =147.0; HRMS calculated for C15H16NO2P 
273.092 found 273.091; [α]D = -28° (c= 1.09, CHCl3). 
 
1H NMR (200 MHz) δ = 7.36-6.78 (m, 9H), 4.21-4.06 (m, 1H), 
3.84 (m, 1H), 1.86 (d, J = 6.8, 3H); 13C NMR (50.32 MHz) δ = 
146.0, 144.5, 128.3, 126.9, 125.6, 121.8, 121.7, 111.6, 11.3, 
50.0, 25.2, 25.2; 31P NMR (81 MHz) δ =137.6; HRMS calculated 
for C14H14NO2P 259.076 found 259.077; [α]D = -205° (c= 1.27, 
CHCl3). 
 
1H NMR (200 MHz) δ = 7.26-7.11 (m, 10H), 6.97 (d, J = 7.7, 
1H), 6.75 (dt, J = 1.1, 7.7, 1H), 6.51 (dt, J = 1.1, 7.7, 1H), 5.95 
(d, J = 7.7, 2H), 2.36-2.25 (m, 2H), 1.67-1.57 (m, 2H); 13C NMR 
(50.32 MHz) δ =145.0, 128.1, 126.8, 126.1, 121.6, 121.2, 111.5, 
110.3, 63.2, 63.1, 33.7; 31P NMR (81 MHz) δ =143.9; HRMS 
calculated for C22H20NO2P 361.122 found 361.123; Anal. Calc. 
for C22H20NO2P: C, 73.12 %; H, 5.58 %; N, 3.88 %, found : C, 
73.09 %; H, 5.58 % ; N, 3.89 %; [α]D = -104° (c= 0.79, CHCl3). 
 
 
1H NMR (200 MHz) δ = 7.40-7.15 (m, 10H), 7.00-6.84 (m, 
8H), 4.24-4.13 (m, 2H), 2.74-2.43 (m, 4H), 1.26 (d, J = 
7,1 Hz, 6H); 13C NMR (50.32 MHz) δ = 146.6, 141.7, 
128.3, 127.2, 121.8, 111.5, 111.3, 55.2, 54.8, 44.5, 44.3, 
20.5, 20.3; 31P NMR (81 MHz) δ =150.1; HRMS 
calculated for C30H30N2O4P2 544.168 found 544.168; [α]D 
































1H NMR (200 MHz) δ = 7.43-7.25 (m, 10H), 7.00-6.82 (m, 
8H), 4.40-4.29 (m, 2H), 2.32-2.15 (m, 4H), 1.49 (dd, J = 
1,71, 7.0, 6H), 1.53-1.21 (m, 4H); 13C NMR (50.32 MHz) 
δ = 146.0, 141.8, 128.4, 127.2, 127.1, 121.7, 111.2, 55.5, 
55.0, 40.3, 40.2, 31.8, 21.5, 21.2; 31P NMR (81 MHz) δ 
=148.5; HRMS calculated for C31H32N2O4P2 558.184 
found 558.184; [α]D = +79° (c= 1.41, CHCl3). 
 
General procedure hydrogenations: 
 
In a glass tube, 0.81 mg (2 µmol) of Rh(COD)2BF4, 4 µmol of ligand (2 µmol in 
case of the bidentate ligands L8 and L9), 200 цmol of the substrate and 4 ml 
of solvent, was added. This small glass tube was placed in a semi-automated 
autoclave with eight reactors (Endeavor ) that was purged 4 times with  
nitrogen and once with hydrogen. Then, the autoclave was pressurized with 5 
or 25 bar of hydrogen. The reaction was stirred for 16 hours. A sample of the 
resulting mixture was filtered over a silica plug and subjected to conversion 
(1H NMR) and e.e. determination (capillary GC). Full conversion was 
observed in most cases. As typical examples the isolated yields for 13, 15, 16 
and 26 were determined. The complete reaction mixtures were filtered over a 
short silica plug (EtOAc) to yield the corresponding products in 99% yield. The 
1H NMR’s of the products are added at the end of the SI. Absolute 
configurations were determined by comparison with reference compounds 
(26, 27, 31), literature values (GC or HPLC injections; 6, 12, 13, 14, 15, 16, 
29),2a,b,c optical rotation (28)2d or assigned by analogy through chiral GC 
elution order (30, 32). 
 






   
1 6 A 6.7 (R) 7.1 (S) 
2 12 B 12.8 (R)  14.9 (S) 
3 13 C 3.4 (R) 3.9 (S) 
4 14 D 11.5 (S) 11.7 (R) 
5 15 E 15.8 (S) 16.7 (R) 
6 16 F 39.4 (S) 41.0 (R) 
7 26 G 12.8 (S) 13.9 (R) 
8 27 H 15.8 (S) 16.7 (R) 
9 28 H 13.5 (S) 14.6 (R) 
10 29 E 9.0 (S) 9.5 (R) 
11 30 I 12.1 (S) 12.7 (R) 
12 31 E 14.0 (S) 15.4 (R) 
13 32 E 17.0 (S) 17.6 (R) 
* Methods A, C-I are GC methods and method B is HPLC method 
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Method A: CP Chiralsil-L-Val from Chrompack (30m x 0.25mm x 0.12µm), 160°C 
Method B: Chiralcel-OD (0.46 cm x 25 cm), i-PrOH: heptane 1:9 
Method C: CP Chiralsil-L-Val from Chrompack (30m x 0.25mm x 0.12µm), 110°C 
Method D: CP Chiralsil-Dex CB from Chrompack (25m x 0.25mm x 0.25µm), 160°C 
Method E: CP Chiralsil-Dex CB from Chrompack (25m x 0.25mm x 0.25µm), 170°C 
Method F: CP Chiralsil-Dex CB from Chrompack (25m x 0.25mm x 0.25µm), 130°C 
Method G: CP Chiralsil-Dex CB from Chrompack (25m x 0.25mm x 0.25µm), 100°C 
Method H: CP Chiralsil-Dex CB from Chrompack (25m x 0.25mm x 0.25µm), 140°C 
Method I: CP Chiralsil-Dex CB from Chrompack (25m x 0.25mm x 0.25µm), 150°C 
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